{
  "retracted": false,
  "timestamp": 1362528000000,
  "updates": [
    {
      "timestamp": 1496003037294,
      "identifier": {
        "doi": "10.1007/s00277-013-1713-5"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s00277-013-1686-4"
  },
  "journal": "Annals of Hematology",
  "publisher": "Springer Nature",
  "title": "Erratum to: High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM"
}
